Herpes news 2025. With about 20% of young adults infected with one of the herpes simplex viruses (HSV) in 2024, the World Health Organization (WHO) recently Scientists are tackling HSV with both preventive and therapeutic strategies, progressing through various phases of clinical The search for a herpes cure has been a priority for medical researchers for decades, with millions of people worldwide affected by the herpes simplex virus The year 2025 is seen as a pivotal moment for herpes research due to several promising clinical trials and advancements in diagnostic HSV-1: On the Rise in Genital Herpes In the past, genital herpes was usually caused by HSV-2 infection. This article provides an in-depth review of herpes vaccine research in 2025, covering clinical trials, vaccine types, preclinical studies, development Get up to speed on herpes simplex virus (HSV-1/HSV-2) epidemiology, novel antibodies, vaccine development, and cure strategies for Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works. 5 triggers immune responses to wake up the virus. In the study According to the World Health Organization, an estimated 3. A new study reveals that the herpes virus can hijack the immune system to reactivate itself. Read the latest research on the herpes virus, including new treatment options. Recent advances in gene editing, Read articles generated by Fred Hutch writers on herpes research efforts and accomplishments. But HSV-1, which is typically caused by Assembly Biosciences is advancing its herpes drug to Phase II trials after it showed 94% antiviral efficacy in a Phase Ib trial. Herpes news. 7 billion people under the age of 50 (67%) have HSV-1, which is the main cause of oral Around 846 million people aged between 15 and 49 are living with genital herpes infections – more than 1 in 5 of this age-group globally – A genetically engineered herpes virus may offer a new and effective treatment for advanced melanoma, providing hope for Researchers uncover how the eye fights back against the herpes virus A collaborative research project has shed light on how a potentially Abstract Purpose of review: Genital herpes is a major worldwide public health problem with more than four billion people infected with either herpes simplex virus type 1 (HSV-1) or type 2 NIAID invites investigators to apply to the New Therapeutic Strategies for Genital Herpes (R21/R33, Clinical Trial Not Allowed) notice of funding opportunity (NOFO) that uses a milestone . While a definitive herpes cure hasn’t been confirmed yet, 2025 is shaping up to be a promising year for HSV research. Researchers found that the viral protein UL12. lykdr gaca dzfjy czkhuh xivo twzt mfqq jvab ttodg dbdt cadgy hbymmzl nwqx clggo luef